Colchicine-placebo 0.5 mg: Clinical Trials

1 trial of Colchicine-placebo 0.5 mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Colchicine-placebo 0.5 mg: new trials by email Literature Review of Colchicine-placebo 0.5 mg trials Research Report on Colchicine-placebo 0.5 mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease
Cardiovascular Polypill (Valsartan, Atorvastatin, Aspirin), Colchicine 0.5 mg, Usual Care Group - Atherothrombotic Diseases, Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3RecruitingHospital do Coracao77132025-06-122026-01-22

Conditions studied

Atherosclerosis (1)

Sponsors

Hospital do Coracao (1)

Countries

Brazil (1)

Top investigators

Erlon Oliveira de Abreu-Silva, M.D (1)